MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Multiple system atrophy(MSA): Pathophysiology"

  • 2018 International Congress

    Peripheral immune activation was associated with multiple system atrophy

    B. Cao, XP. Chen, WH. Feng, QQ. Wei, LY. Zhang, HF. Shang (Chengdu, China)

    Objective: Our aim is to clarify the correlations between peripheral immune activation and the prevalence as well as the disease severity of MSA. Background: Alpha-synuclein…
  • 2018 International Congress

    Role of uric acid as a prognostic biomarker in Idiopathic Parkinson’s disease and Parkinson Plus Syndrome

    T. Modi, M. Goyal, J. Kaur, B. Medhi (Chandigarh, India)

    Objective: To estimate the levels of serum uric acid in Idiopathic Parkinson’s disease (IPD) and various Parkinson plus syndromes (PPS). To correlate the uric acid…
  • 2017 International Congress

    To Study the Role of Biomarkers DJ-1 and Apo A1 in Idiopathic Parkinson’s Disease and Parkinson Plus Syndromes in Indian Population

    M. Modi, R. Shree, S. Mehta, M. Goyal, B. Medhi, V. Lal, B. Mittal (Chandigarh, India)

    Objective: To study the role of serum DJ-1 and Apo A1 in the diagnosis and differentiation of Idiopathic Parkinson Disease (IPD) and Parkinson Plus Syndromes(PPS)…
  • 2017 International Congress

    Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy

    W. Meissner, F. Bassil, P. Guerin, N. Dutheil, Q. Li, M. Klugmann, E. Bezard, P.-O. Fernagut (Bordeaux, France)

    Objective: We aimed to develop AAV-based models of MSA Background: Multiple system atrophy (MSA) is a fatal neurodegenerative disorder characterized by a combination of autonomic…
  • 2017 International Congress

    Profound reduction of DAT-SPECT signal in multiple system atrophy (MSA)

    I. Toyoshima, T. Hatakeyama, E. Abe, C. Wada, M. Kobayashi, K. Obara (Yurihonjo, Japan)

    Objective: To evaluate the extent of degeneration in dopamine nerve terminal in striatum in the patients with MSA-P and MSA-C, and to compare the progression…
  • 2017 International Congress

    Cardiac Autonomic Dysregulation in Probable Multiple System Atrophy

    M. Rukmani, R. Yadav, P. Pal, B. Bhaskarapillai, T. Sathyaprabha (Bangalore, India)

    Objective: The objective was to retrospectively study the nature of cardiac autonomic dysfunction and the effect of phenotype on it in probable Multiple System Atrophy…
  • 2017 International Congress

    Metabolomics study in a group of Parkinson’s disease patients from Northern India

    G.N. Babu, M. Gupta, V.K. Paliwal, S. Singh, R. Roy (Lucknow, India)

    Objective: To do (1) H NMR study in a group of Parkinson’s disease patients, disease controls, viz. multiple system atrophy (MSA) and progressive supra nuclear…
  • 2017 International Congress

    Antibody binding differences in alpha-synuclein from Parkinson’s disease and multiple system atrophy

    T. Yamasaki, A. Welleford (Lexington, KY, USA)

    Objective: Determine whether alpha-synuclein derived from Parkinson's disease (PD) and multiple system atrophy (MSA) brains has different conformations as defined by biochemical and antibody-based approaches. Background: There…
  • 2017 International Congress

    MRI-based Brain Networks of Perfusion and Structural Abnormalities in Patients with Cerebellar Variant of Multiple System Atrophy

    P. Wu, S. Peng, J. Ge, J. Wang, D. Eidelberg, C. Zuo, Y. Ma (Shanghai, China)

    Objective: To identify MRI-based brain networks of cerebral perfusion and structural abnormalities in cerebellar variant of MSA.  Background: MSA consists clinically of parkinsonian (MSA-P) and cerebellar (MSA-C) variants. Previous FDG PET studies have…
  • 2017 International Congress

    Specific Metabolic Brain Networks Associated with Parkinsonian and Cerebellar Variants of Multiple System Atrophy

    P. Wu, S. Peng, J. Wang, J. Wu, C. Jiang, J. Ge, D. Eidelberg, Y. Ma, C. Zuo (Shanghai, China)

    Objective: To identify specific metabolic brain networks for parkinsonian (MSA-P) and cerebellar (MSA-C) variants of MSA. Background: MSA is associated with a disease-related metabolic brain network (MSARP)…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley